Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Spire Healthcare GroupCHIX:SPIL 73 3-Year EPS without NRI Growth Rate is 31.90% as of Dec. 2025. GuruFocus rates CHIX:SPIL with a GF Score™ of 73/100 and a GF Value™ of £2.71 (Modestly Undervalued). The stock has 10 warning signs investors should review. Among 507 Healthcare Providers & Services companies, Spire Healthcare Group ranks better than 75.54% on this metric.
During the past 12 months, Spire Healthcare Group's average EPS without NRI Growth Rate was 9.30% per year.
During the past 3 years, the average EPS without NRI Growth Rate was 31.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Spire Healthcare Group was 31.90% per year. The lowest was -49.90% per year. And the median was -9.45% per year.
Spire Healthcare Group (CHIX:SPIl) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Spire Healthcare Group 3-Year EPS without NRI Growth Rate Related Terms
CHIX:SPIL vs HCA, THC, DVA: 3-Year EPS without NRI Growth Rate Comparison
For the Medical Care Facilities subindustry, Spire Healthcare Group's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Spire Healthcare Group 3-Year EPS without NRI Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Spire Healthcare Group's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Spire Healthcare Group's 3-Year EPS without NRI Growth Rate falls into.
Spire Healthcare Group 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 31.90% mean?
Spire Healthcare Group (CHIX:SPIL) has a 3-Year EPS without NRI Growth Rate of 31.90% as of Dec. 2025. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Spire Healthcare Group and its competitors. According to the industry distribution chart, Spire Healthcare Group ranks #124 out of 507 companies in the Healthcare Providers & Services industry, placing it in the top 24.5%.
Is Spire Healthcare Group's 3-Year EPS without NRI Growth Rate too high?
Spire Healthcare Group's current 3-Year EPS without NRI Growth Rate is 31.90%. The Healthcare Providers & Services industry median 3-Year EPS without NRI Growth Rate is 11.00. Spire Healthcare Group's value of 31.90% is 190% above this industry median. Based on the distribution chart, Spire Healthcare Group ranks #124 out of 507 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Spire Healthcare Group has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Spire Healthcare Group's 3-Year EPS without NRI Growth Rate compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Spire Healthcare Group ranks #124 out of 507 companies for 3-Year EPS without NRI Growth Rate. This places Spire Healthcare Group in the top 25% of its industry — outperforming the majority of peers. The industry median 3-Year EPS without NRI Growth Rate is 11.00. Spire Healthcare Group's value of 31.90% is 190% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EPS without NRI Growth Rate among Healthcare Providers & Services companies is 11.00, based on 507 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Spire Healthcare Group's current 3-Year EPS without NRI Growth Rate of 31.90% is 190% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Spire Healthcare Group and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EPS without NRI Growth Rate is 11.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Spire Healthcare Group's current 3-Year EPS without NRI Growth Rate is 31.90%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spire Healthcare Group stock overvalued right now?
Based on GuruFocus' analysis, Spire Healthcare Group (CHIX:SPIL) is currently considered Modestly Undervalued. The stock's GF Value™ is £2.71, compared to a current price of £2.36 — trading 12.9% below its estimated fair value. The current 3-Year EPS without NRI Growth Rate is 31.90% and 190% above the Healthcare Providers & Services industry median of 11.00. Spire Healthcare Group's overall GF Score™ is 73/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For Spire Healthcare Group (CHIX:SPIL), the current 3-Year EPS without NRI Growth Rate is 31.90% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Spire Healthcare Group (CHIX:SPIL) Overvalued in 2026?
Based on GuruFocus' analysis, Spire Healthcare Group stock appears to be undervalued.
The current stock price of £2.36 is trading 12.9% below its estimated GF Value™ of £2.71.
GuruFocus considers Spire Healthcare Group to be Modestly Undervalued.
Key valuation signals for CHIX:SPIL:
3-Year EPS without NRI Growth Rate: 31.90%
GF Value™: £2.71 vs. price of £2.36 (12.9% below fair value)
Industry Position: 190% above the Healthcare Providers & Services median (#124 of 507)
No single metric tells the full story. See the CHIX:SPIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Spire Healthcare Group PLC is an independent hospital group in the United Kingdom. It is a private provider, by volume, of knee and hip operations in the United Kingdom. The company has two operating segments: the hospitals business and the Primary care. The company generates the majority of its revenue from Hospital Business, which consists of hospitals, clinics, medical centres and consulting rooms. The company provide diagnostics, inpatient, day case and outpatient care in areas including orthopaedics, gynaecology, cardiology, neurology, oncology and general surgery. The primary care segment encompasses services focused on the primary care needs of outpatients, including GP services, occupational health services or mental and physical health services.
73GF Score
Get the complete analysis for CHIX:SPIL
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:SPIL has been successfully added to your 
